drugset / Trial / NCT00000227
Alternate-Day Buprenorphine Administration. Phase VIII - 9
CrossoverTreatment
Summary
The purpose of this study is to evaluate open buprenorphine dosing with dose choice.
Timeline
- Start
- 1994-08
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Buprenorphine | Other / unclassified | — | — |